Big pharma
Large drugmakers that sell many branded medicines for a wide range of illnesses around the world.
+15.4%
over 3 months · S&P 500 −2.1%
Key indicators
Health
57 / 100
Fragile
Solid
Price
P/E 28
Cheap
Expensive
Up over 1 year
13 of 15
Wallets over 90 days
2 / 5 buys / sells
Buys
Sells
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 16 companies
LLY
+22.0%
JNJ
+9.4%
ABBV
+17.9%
MRK
AMGN
+11.7%
GILD
+21.7%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
L
Eli Lilly
LLY
36.9%
+22.0%
J
Johnson & Johnson
JNJ
18.3%
+9.4%
A
AbbVie
ABBV
14.3%
+17.9%
M
Merck
MRK
9.9%
+9.3%
A
Amgen
AMGN
6.9%
+11.7%
G
Gilead Sciences
GILD
5.7%
+21.7%
P
Pfizer
PFE
4.6%
+9.1%
B
Bristol-Myers Squibb
BMY
3.4%
−0.8%
A
AstraZeneca
AZN
+17.6%
B
Bayer
BAYRY
0.0%
G
GSK
GSK
+0.3%
N
Novo Nordisk
NVO
−7.2%
N
Novartis
NVS
+5.6%
R
Roche Holdings
RHHBY
0.0%
S
Sanofi
SNY
+8.9%
T
Takeda Pharmaceutical
TAK
+23.3%